Real-world data and real-world evidence are important when it comes to cancer research because they can complement and expand findings from randomized clinical trials
This registry study is collecting real-world data on patients with advanced, EGFR-positive non-small cell lung cancer who may not have had the opportunity, wanted to, or been eligible to enroll in a trial